These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32525782)

  • 1. Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In Vitro Assay.
    Al-Sha'er MA; Taha MO
    Curr Comput Aided Drug Des; 2021; 17(4):511-522. PubMed ID: 32525782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis.
    Al-Sha'er MA; Al-Aqtash RA; Taha MO
    Med Chem; 2019; 15(6):588-601. PubMed ID: 30799792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores.
    Al-Sha'er MA; Basheer HA; Taha MO
    Mol Divers; 2023 Feb; 27(1):443-462. PubMed ID: 35507210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.
    Tuffaha GO; Hatmal MM; Taha MO
    J Mol Graph Model; 2019 Sep; 91():30-51. PubMed ID: 31158642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmenting bioactivity by docking-generated multiple ligand poses to enhance machine learning and pharmacophore modelling: discovery of new TTK inhibitors as case study.
    Al-Imam AM; Daoud S; Hatmal MM; Taha MO
    Mol Inform; 2023 Jun; 42(6):e2300022. PubMed ID: 37222400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
    Taha MO; Al-Sha'er MA; Khanfar MA; Al-Nadaf AH
    Eur J Med Chem; 2014 Sep; 84():454-65. PubMed ID: 25050878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Potent Bruton's Tyrosine Kinase Inhibitors Using Ligand Based Modeling.
    Mera WA; Alzihlif M; Taha MO; Khanfar MA
    Anticancer Agents Med Chem; 2017; 17(2):265-275. PubMed ID: 27671297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH; Taha MO
    J Mol Graph Model; 2011 Apr; 29(6):843-64. PubMed ID: 21376648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH; Zihlif MA; Taha MO
    Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents.
    Mansi I; Al-Sha'er MA; Mhaidat N; Taha M
    Anticancer Agents Med Chem; 2020; 20(4):476-485. PubMed ID: 31889497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors.
    Khanfar MA; Taha MO
    J Mol Recognit; 2017 Sep; 30(9):. PubMed ID: 28299833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.
    Shahin R; Swellmeen L; Shaheen O; Aboalhaija N; Habash M
    J Comput Aided Mol Des; 2016 Jan; 30(1):39-68. PubMed ID: 26685860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
    Al-Sha'er MA; Khanfar MA; Taha MO
    J Mol Model; 2014 Jan; 20(1):2080. PubMed ID: 24469103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore and 3D-QSAR characterization of 6-arylquinazolin-4-amines as Cdc2-like kinase 4 (Clk4) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) inhibitors.
    Pan Y; Wang Y; Bryant SH
    J Chem Inf Model; 2013 Apr; 53(4):938-47. PubMed ID: 23496085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO; Tarairah M; Zalloum H; Abu-Sheikha G
    J Mol Graph Model; 2010 Jan; 28(5):383-400. PubMed ID: 19850503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors.
    Khanfar MA; Taha MO
    J Chem Inf Model; 2013 Oct; 53(10):2587-612. PubMed ID: 24050502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling.
    Zalloum H; Tayyem R; Irmaileh BA; Bustanji Y; Zihlif M; Mohammad M; Rjai TA; Mubarak MS
    J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling of JAK1: A target infested with activity-cliffs.
    Daoud S; Taha MO
    J Mol Graph Model; 2020 Sep; 99():107615. PubMed ID: 32339898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.
    Taha MO; Atallah N; Al-Bakri AG; Paradis-Bleau C; Zalloum H; Younis KS; Levesque RC
    Bioorg Med Chem; 2008 Feb; 16(3):1218-35. PubMed ID: 17988876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling.
    Al-Najjar BO; Wahab HA; Tengku Muhammad TS; Shu-Chien AC; Ahmad Noruddin NA; Taha MO
    Eur J Med Chem; 2011 Jun; 46(6):2513-29. PubMed ID: 21482446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.